Clinical Trial Update: A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects [Phase 2]

View source ↗

Summary

This document reports on a Phase 2 study evaluating pramlintide’s effect on body weight and its safety and tolerability in obese subjects, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• pramlintide (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Obesity | Phase 2 | Status: COMPLETED